{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import json\n",
    "from pprint import pprint\n",
    "from copy import deepcopy\n",
    "\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import json\n",
    "import glob\n",
    "import sys\n",
    "\n",
    "sys.path.insert(0, \"../\")\n",
    "\n",
    "root_path = '/Users/u6066091/Desktop/kaggle/input/corona_challenge/'\n",
    "\n",
    "corona_features = {\"doc_id\": [None], \"source\": [None], \"title\": [None],\n",
    "                  \"abstract\": [None], \"text_body\": [None]}\n",
    "corona_df = pd.DataFrame.from_dict(corona_features)\n",
    "\n",
    "json_filenames = glob.glob(f'{root_path}/**/*.json', recursive=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "# json_filenames = '/Users/u6066091/Downloads/enriched_covid_df224.json'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(json_filenames) as f:\n",
    "    data = json.load(f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "652"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['doc_id', 'title', 'abstract', 'text_body', 'publish_time', 'authors',\n",
       "       'journal', 'doi', 'H index', 'full_text', 'section', 'total_rank',\n",
       "       'risk_factors', 'match_indices', 'smoking_count', 'has_smoking?',\n",
       "       'smoking_in_title', 'diabetes_count', 'has_diabetes?',\n",
       "       'diabetes_in_title', 'pregnancy_count', 'has_pregnancy?',\n",
       "       'pregnancy_in_title', 'tuberculosis_count', 'has_tuberculosis?',\n",
       "       'tuberculosis_in_title', 'hypertension_count', 'has_hypertension?',\n",
       "       'hypertension_in_title', 'cancer_count', 'has_cancer?',\n",
       "       'cancer_in_title', 'neonates_count', 'has_neonates?',\n",
       "       'neonates_in_title', 'liver disease_count', 'has_liver disease?',\n",
       "       'liver disease_in_title', 'COPD_count', 'has_COPD?', 'COPD_in_title',\n",
       "       'pulmonary disease_count', 'has_pulmonary disease?',\n",
       "       'pulmonary disease_in_title', 'race/ethnicity_count',\n",
       "       'has_race/ethnicity?', 'race/ethnicity_in_title', 'design',\n",
       "       'design_rank', 'outcomes', 'outcome_rank', 'fatality_rank',\n",
       "       'has_fatality_info?', 'section_rank', 'scibert_summary'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_json(json_filenames, orient=\"records\")\n",
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 326,
   "metadata": {},
   "outputs": [],
   "source": [
    "root = '/Users/u6066091/Desktop/kaggle'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "root = '/Users/u6066091/Desktop/kaggle'\n",
    "Design_list = [ 'retrospective cohort', 'cross-sectional case-control','cross sectional case control',\n",
    "               'prevalence survey', 'systematic review ',' meta-analysis',' meta analysis'\n",
    "               'matched case-control', 'matched case control','medical record review', 'observational case series', \n",
    "               'time series analysis','pseudo-randomized controlled trials' ,'pseudo randomized controlled trial',\n",
    "               'randomized controlled trials','randomized controlled trial']\n",
    "risk_factors = pd.read_csv(root + '/input/kaggle_annotated/COVID-19 medical_dictionary-difference.dictionary.csv')\n",
    "cov_list = ['covid-19','covid 19', 'novel coronavi','cord-19' ,'cord 19','2019-nCoV', \n",
    "            '2019 ncov','2019 cov', 'wuhan coronavi', 'cov_2', 'cov-2', ]\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# This is how the keywords were extracted"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Question\n",
    "#'Range of incubation periods for the disease in humans (and how this varies across \n",
    "#age and health status) and how long individuals are contagious, even after recovery.'\n",
    "\n",
    "\n",
    "# import pandas as pd\n",
    "# from nltk.stem.porter import *\n",
    "# from nltk.stem.snowball import SnowballStemmer\n",
    "# stemmer = SnowballStemmer(\"english\", ignore_stopwords=False)\n",
    "\n",
    "# design = pd.read_csv('COVID-19_dictionary_sub_question.csv')\n",
    "# trans_data = design[design['Task'] =='What is known about transmission, incubation, and environmental stability? What do we know about natural history, transmission, and diagnostics for the virus? What have we learned about infection prevention and control?']\n",
    "\n",
    "# trans_outcome = list(set([trans_data.loc[i,'Outcome.list'] for i in range(0,4)])) \n",
    "# trans_desig =  list(set([trans_data.loc[i,'Design.list'] for i in range(0,4)]))\n",
    "# trans_ris =    list(set([trans_data.loc[i,'Differences.list']  for i in range(0,4)]))\n",
    "\n",
    "\n",
    "transmission=[['incubation','period','range'],\n",
    "['viral','shedding','duration'],\n",
    "['asymptomatic','shedding'],\n",
    "['incubation','period','age','statistically','significant'],\n",
    "['incubation','period','child'],\n",
    "['incubation','groups','risk'],\n",
    "['basic','reproduction', 'number','%'],\n",
    "['asymptomatic','infection','%'],\n",
    "['asymptomatic','children'],\n",
    "['seasonal','transmission'],\n",
    "['contaminat','object'],\n",
    "['environmental', 'conditions'],\n",
    "['sputum','stool','blood','urine'],\n",
    "['persistence','surfaces'],\n",
    "['duration','viral','shedding'],\n",
    "['shedding','stool'],\n",
    "['shedding','nasopharynx'],\n",
    "['shedding','blood'],\n",
    "['shedding','urine'],\n",
    "['diagnostics','point'],\n",
    "['model', 'disease'],        \n",
    "['model', 'infection'],\n",
    "['model', 'transmission'],\n",
    "['phenotypic'],\n",
    "['mutation'],\n",
    "['immune','response'],\n",
    "['restriction', 'movement'],\n",
    "['protective','clothing'],\n",
    "['transmission','routes']\n",
    "]\n",
    "\n",
    "trans_outcom = ['risk','range','duration','asymptomatic',\n",
    " 'infecti', 'reproducti',  'route', \n",
    " 'age','transm'\n",
    " 'stratifi',\n",
    " 'period,',\n",
    " 'health',\n",
    " 'r0','shedd', 'viral'\n",
    " 'period','incub',\n",
    " 'generat',\n",
    " 'factor',\n",
    " 'interval,',\n",
    " 'serial']\n",
    "\n",
    "des1 = ['mathemat',\n",
    " 'profil', 'cross sectional case control', 'matched case control',\n",
    " 'contact',\n",
    " 'surviv',\n",
    " 'tracing,',\n",
    " 'time to event',\n",
    "  'time-to-event',            \n",
    " 'risk factor analysis', \n",
    "'logistic regression', 'cross-sectional case-control', 'matched case-control', \n",
    "    'observational case series', 'time series analysis', 'survival analysis',\n",
    " 'investigati',\n",
    " 'model',\n",
    " 'outbreak',\n",
    " 'stochast',\n",
    " 'statist',\n",
    " 'analysi',\n",
    " 'experiment',\n",
    " 'excret',\n",
    " 'investig']\n",
    "\n",
    "des2 = ['retrospective cohort', 'cross-sectional case-control','cross sectional case control',\n",
    "               'prevalence survey', 'systematic review ','meta-analysis','meta analysis',\n",
    "               'matched case-control', 'matched case control','medical record review', 'observational case series', \n",
    "               'time series analysis','pseudo-randomized controlled' ,'pseudo randomized controlled',\n",
    "               'randomized controlled','retrospective analysis','retrospective study','retrospective studies']\n",
    "\n",
    "trans_risk =['diabete','age','neonat','elderly,',\n",
    " 'cancer','histori','sputum','stool','blood','urine', \n",
    " 'house','environmental', 'seasonal', 'comorbidit',' immune deficiency', 'liver',\n",
    " 'smok','age decil','heart','lung','climate,', 'PPE use', 'touching face',\n",
    " 'immun','insur','compromis', 'pregnan','race', 'ethnic','hyperten','child', 'tubercul', 'mtb','tb','MTB', 'TB']\n",
    "# trans_desi = list(set(des1 +des2))\n",
    "trans_desi = des2\n",
    "trans_risk =['asthm']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "# filter for more recent data (past 2019) that have covid in their title\n",
    "import pandas as pd\n",
    "import re\n",
    "\n",
    "metadata = pd.read_csv(root+ '/output/corona_challenge/all_data_metadata.csv')\n",
    "recent_data = metadata[metadata['publish_time'] >= '2019'].reset_index(drop = True)[['doc_id', 'source', 'title', 'abstract_x', 'text_body',\n",
    "       'sha', 'source', 'doi', 'pmcid', 'pubmed_id', 'license', \n",
    "       'publish_time', 'authors', 'journal', 'Microsoft Academic Paper ID',\n",
    "       'WHO #Covidence', 'has_full_text', 'full_text_file']]\n",
    "cov_title = [title for title in recent_data['title'] if any((re.search(cov,title.lower())) for cov in cov_list)]\n",
    "data = recent_data[recent_data['title'].isin(cov_title)].reset_index(drop = True)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "import json\n",
    "import numpy as np\n",
    "risk_design_outcome =[]\n",
    "smoke = []\n",
    "diabete = []\n",
    "pregnan = []\n",
    "race = []\n",
    "# smoking/diabetes / pregnancy/race\n",
    "for i in range(0,len(json_filenames)):\n",
    "     with open(json_filenames[i]) as file:\n",
    "        data_2 = json.load(file)\n",
    "        if any((re.search(cov,data_2['metadata']['title'].lower())) for cov in cov_list):\n",
    "            for ii in range(0, len(data_2['body_text'])):\n",
    "\n",
    "                risk1 = [re.findall(risk,data_2['body_text'][ii]['text']) for risk in trans_risk]\n",
    "                risk1 = np.concatenate(risk1)\n",
    "                if any(risk1):\n",
    "                    risk_design_outcome.append([data_2['paper_id'],data_2['metadata']['title']\n",
    "                                        ,data_2['body_text'][ii]['section'], data_2['body_text'][ii]['text'],risk1])\n",
    "#                                        \n",
    "                    \n",
    "#                     if 'smok' in risk1:\n",
    "#                         flag_smoke ='yes'\n",
    "#                         n_smoke = len([ s for s in risk1 if s == 'smok'])\n",
    "#                     else:\n",
    "#                         flag_smoke = 'no'\n",
    "#                         n_smoke = 0\n",
    "#                     title_smoke = 'no'    \n",
    "#                     if 'somk' in data_2['metadata']['title'].lower():\n",
    "#                         title_smoke = 'yes'\n",
    "#                         n_smoke = 10+ n_smoke\n",
    "                        \n",
    "#                     if 'diabete'in risk1:\n",
    "#                         flag_diabete ='yes'\n",
    "#                         n_diabete = len([ s for s in risk1 if s == 'diabete'])\n",
    "#                     else:\n",
    "#                         flag_diabete = 'no'\n",
    "#                         n_diabete = 0\n",
    "#                     title_diabete = 'no'    \n",
    "#                     if 'diabete' in data_2['metadata']['title'].lower():\n",
    "#                         title_diabete = 'yes'\n",
    "#                         n_diabete = 10+ n_diabete\n",
    "                        \n",
    "#                     if 'pregnan'in risk1:\n",
    "#                         flag_pregnan ='yes'\n",
    "#                         n_pregnan = len([ s for s in risk1 if s == 'pregnan'])\n",
    "#                     else:\n",
    "#                         flag_pregnan = 'no'\n",
    "#                         n_pregnan = 0\n",
    "#                     title_pregnan = 'no'    \n",
    "#                     if 'pregnan' in data_2['metadata']['title'].lower():\n",
    "#                         title_pregnan = 'yes'\n",
    "#                         n_pregnan = n_pregnan +10\n",
    "                    \n",
    "#                     if ('tubercul' or 'MTB' or 'TB') in risk1:\n",
    "#                         flag_race ='yes'\n",
    "#                         n_race = len([ s for s in risk1 if s == ('tubercul' or 'MTB' or 'TB' or 'tb' or 'mtb')])\n",
    "#                     else:\n",
    "#                         flag_race = 'no'\n",
    "#                         n_race = 0\n",
    "#                     title_race = 'no'    \n",
    "#                     if 'tubercul' in data_2['metadata']['title'].lower():\n",
    "#                         title_race = 'yes'\n",
    "#                         n_race = n_race + 0\n",
    "                        \n",
    "#                 design = [re.findall(des,data_2['body_text'][ii]['text']) for des in trans_desi]\n",
    "#                 design = np.concatenate(design)\n",
    "#                 design_rank = 0\n",
    "#                 if any(design):\n",
    "                    \n",
    "#                     if ('meta-analysis'or 'meta analysis') in design:\n",
    "#                         flag_meta_analysis = 'yes'\n",
    "#                         design_rank = 6\n",
    "#                     if ('randomized controlled') in design:\n",
    "#                         design_rank = 5\n",
    "#                         flag_randomized = 'yes'\n",
    "#                     if ('pseudo-randomized controlled' or'pseudo randomized controlled') in design:\n",
    "#                         design_rank = 4\n",
    "#                         flag_pseudo_randomized = 'yes'\n",
    "#                     design_rank = design_rank + len(design)  \n",
    "                    \n",
    "#                 outcome_rank = 0\n",
    "#                 outcome = [re.findall(des,data_2['body_text'][ii]['text']) for des in trans_outcom]\n",
    "#                 outcome = np.concatenate(outcome)\n",
    "#                 if any(outcome):\n",
    "#                     outcome_rank = len(outcome)\n",
    "                \n",
    "#                 if flag_smoke == 'yes':\n",
    "#                     smoke.append([data_2['paper_id'],data_2['metadata']['title']\n",
    "#                                        ,data_2['body_text'][ii]['section'], data_2['body_text'][ii]['text']\n",
    "#                                        ,risk1, title_smoke, n_smoke\n",
    "#                                        , design, outcome, outcome_rank,design_rank,data_2['body_text']])\n",
    "            \n",
    "#                 if flag_diabete == 'yes':\n",
    "#                     diabete.append([data_2['paper_id'],data_2['metadata']['title']\n",
    "#                                        ,data_2['body_text'][ii]['section'], data_2['body_text'][ii]['text']\n",
    "#                                        ,risk1, title_diabete, n_diabete\n",
    "#                                       , design, outcome, outcome_rank,design_rank,data_2['body_text']])\n",
    "#                 if flag_pregnan == 'yes':\n",
    "#                     pregnan.append([data_2['paper_id'],data_2['metadata']['title']\n",
    "#                                        ,data_2['body_text'][ii]['section'], data_2['body_text'][ii]['text']\n",
    "#                                        ,risk1, title_pregnan, n_pregnan\n",
    "#                                       , design, outcome, outcome_rank,design_rank, data_2['body_text']]) \n",
    "#                 if flag_race == 'yes':\n",
    "#                     race.append([data_2['paper_id'],data_2['metadata']['title']\n",
    "#                                        ,data_2['body_text'][ii]['section'], data_2['body_text'][ii]['text']\n",
    "#                                        ,risk1, title_race, n_race\n",
    "#                                       , design, outcome, outcome_rank,design_rank]) \n",
    "                            \n",
    "                        \n",
    "#                 risk_design_outcome.append([data_2['paper_id'],data_2['metadata']['title']\n",
    "#                                        ,data_2['body_text'][ii]['section'], data_2['body_text'][ii]['text']\n",
    "#                                        ,risk1, flag_smoke, title_smoke, n_smoke, flag_diabete, title_diabete, n_diabete\n",
    "#                                        , flag_pregnan, title_pregnan, n_pregnan, flag_race, title_race, n_race\n",
    "#                                       , design, outcome, outcome_rank,design_rank] ) \n",
    "                \n",
    "#                 "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[['74d892305c62c72247aa1d35e1a42769638219d6',\n",
       "  'Journal Pre-proof 2019-novel coronavirus outbreak: A new challenge 2019-novel Coronavirus Outbreak: A New Challenge',\n",
       "  'Results: Patients Characteristics',\n",
       "  'J o u r n a l P r e -p r o o f Huang et al. and Wang et al. [1, 12] have shown a rate of chronic obstructive pulmonary disease (COPD) of about 2% and 2,9%, respectively. Subsequently Chen et al. [10] have reported a rate of about 1% of respiratory system diseases, different from an estimated COPD prevalence between 1.2-8.9% in different regions of China [16] . Moreover, interstitial lung diseases, history of smoking, bronchiectasis or asthma were underreported [1, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Diabetes was firstly mentioned by Huang and colleagues [9] and represented the main comorbidity in their cohort (8; 20%) and afterwards other Authors [11] [12] reported diabetes in about 10% of subjects. Furthermore, among cases outside Asia, Holshue et al. [4] have mentioned hypertriglyceridemia as the sole chronic illness of the first U.S. case of 2019-nCoV; on the other hand, German cases [6] were overall healthy.',\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['5b0ccee8385f0a382fccfbf73f2bdc5518d4fcdb',\n",
       "  'Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells',\n",
       "  '. Introduction',\n",
       "  'Human coronaviruses (HCoV)-229E and HCoV-OC43 cause the common cold [1, 2] and exacerbate chronic obstructive pulmonary disease (COPD) and bronchial asthma [3, 4] . HCoV-229E binds to the aminopeptidase N receptor (CD13) [5] and enters cells via endosomal and cell-surface pathways using proteases [6, 7] . HCoV-229E can replicate in an airway epithelial cell line [8] ; however, HCoV-229E replication in primary human airway epithelial cell cultures has not been studied.',\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['5b0ccee8385f0a382fccfbf73f2bdc5518d4fcdb',\n",
       "  'Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells',\n",
       "  '. Introduction',\n",
       "  'Long-acting muscarinic antagonists (LAMAs), long-acting b 2 -agonists (LABAs), and inhaled corticosteroids (ICSs) prevent COPD and bronchial asthma exacerbation [9, 10] induced by viral infection, including infection with HCoV-229E [3, 4] . We reported that the LAMA tiotropium, the LABA formoterol, and the ICS budesonide reduce rhinovirus replication by reducing receptor expression and/or the number of acidic endosomes where rhinoviral RNA enters the cytoplasm [11, 12] . Acidic endosomes are also critical for the entry of HCoV-229E [7] ; however, the effects of these drugs on HCoV-229E replication are unknown.',\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['5b0ccee8385f0a382fccfbf73f2bdc5518d4fcdb',\n",
       "  'Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells',\n",
       "  'HNE and HTE cells',\n",
       "  'Nasal polyps were obtained from 50 subjects with chronic rhinosinusitis (age; 55 ± 2 y) undergoing endoscopic surgery. Tracheal samples were obtained from 10 patients after death (age; 69 ± 4 years). The sex, reason for surgery, cause of death, presence of allergic rhinitis, bronchial asthma, or COPD, as well as the drugs used for treatment, are shown in Table 1 .',\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['5b0ccee8385f0a382fccfbf73f2bdc5518d4fcdb',\n",
       "  'Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells',\n",
       "  'Effects on HCoV-229E replication in HNE cells',\n",
       "  'The peak titers in cells from asthmatic patients (5.11 ± 0.28 log 10 TCID 50 /mL, n ¼ 18; TCID: tissue culture infective dose), which were defined according to the 2017 Global Initiative for Asthma guidelines [10] , or the titers from allergic rhinitis patients (4.80 ± 0.37 log 10 TCID 50 /mL, n ¼ 10), tended to be higher than those from patients without asthma and allergic rhinitis (4.36 ± 0.61 log 10 TCID 50 /mL, n ¼ 12). However, these differences were not significant (p > 0.10). Pretreatment with glycopyrronium, formoterol, and GFB decreased the HCoV-229E RNA levels at 72 h after infection, and ICI reversed the effects of formoterol (Fig. 1G) . The HCoV-229E RNA levels in GFB-pretreated cells were lower than those in cells treated with glycopyrronium, formoterol, or budesonide alone (Fig. 1G ). The results are presented as the mean ± SEM of five (A-D, FeH) or seven (E) subjects. Significant differences compared with cells pretreated with vehicle are indicated by *p < 0.05, **p < 0.01, and ***p < 0.001. Significant differences compared with cells treated with glycopyrronium, formoterol, and budesonide are indicated by ‡ p < 0.05, y p < 0.05, and § p < 0.05, respectively. ',\n",
       "  array(['asthm', 'asthm'], dtype='<U5')],\n",
       " ['5b0ccee8385f0a382fccfbf73f2bdc5518d4fcdb',\n",
       "  'Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells',\n",
       "  'Discussion',\n",
       "  'IL-6 and IL-8 are related to airway inflammation in COPD and bronchial asthma exacerbation induced by viral infection [4, 13] . The decreased production of IL-6 and IL-8 in cells pretreated with glycopyrronium, formoterol, and budesonide, as well as the increased inhibitory effects of GFB observed in the present study, may be associated with the inhibitory effects of these drugs on COPD and bronchial asthma exacerbation [9, 10] .',\n",
       "  array(['asthm', 'asthm'], dtype='<U5')],\n",
       " ['5b0ccee8385f0a382fccfbf73f2bdc5518d4fcdb',\n",
       "  'Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells',\n",
       "  'Discussion',\n",
       "  'HNE and HTE cells have been used in several studies of respiratory viral infection [43e45]. Here, we used HNE and HTE cells because we previously used these cells in infection studies [11, 12, 15, 46] . However, because bronchi and alveoli are the main sites of the pathogenesis of COPD and bronchial asthma exacerbations, bronchial and alveolar epithelial cells were used to reveal the effects of viral infection on exacerbations and the effects of drugs [37, 47] . Therefore, further studies using bronchial and alveolar epithelial cells will be needed to confirm HCoV-229E replication and the effects of drugs.',\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['200917c95e6477ab725eacda21ebdc3548c3fd95',\n",
       "  'What we know so far: COVID-19 current clinical knowledge and research',\n",
       "  'COVID-19 is classified as an airborne high consequence infectious disease (HCID) in the UK. The cornerstone of management of all possible or confirmed cases is early triage and isolation.',\n",
       "  'Notably, if a history is elicited that suggests a possible case once consultation has already commenced, examination should be abandoned and the practitioner should leave the room, close the door, and wash their hands thoroughly with soap and water. The studies found possible evidence of harm, such as delayed viral clearance, psychosis, diabetes and avascular necrosis. 16 Evidence from management of MERS-CoV also suggests corticosteroids may delay viral clearance. 17 However, other indications for corticosteroids such as exacerbation of asthma could potentially supervene. Remdesivir, a novel nucleotide analogue prodrug with activity against MERS-CoV in mouse models has been given to one COVID-19 patient in the USA on a compassionate basis without adverse events, and randomised controlled trials formally investigating its use in COVID-19 infection have already been registered. [18] [19] [20] [21] Detailed guidance intended for the management of COVID-19 cases developing severe acute respiratory illness has been published by the World Health Organization (WHO) and is available online at www.who.int/emergencies/diseases/novelcoronavirus-2019 ; it is likely to be regularly updated and is therefore not reproduced here.',\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['95cc4248c19a3cc9a54ebcfa09fc7c80518dac5d',\n",
       "  'Journal Pre-proof Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods',\n",
       "  '3C-like main protease (3CLpro)',\n",
       "  \"It's worth mentioning, anti-asthmatic drug montelukast also showed low binding energy to 3CLpro. As shown in Fig. 5A , montelukast was well fitted into the active pocket of 3CLpro, in which lots of hydrophobic amino acids, just like Thr24, Leu27, His41, Phe140, Cys145, His163, Met165, Pro168 and His172 compose a relatively hydrophobic environment to contain the compound and stabilize its conformation. Hydrogen bonding was predicted between Asn142 and the carbonyl group of the compound (Fig. 5B ). DNA and RNA along the 5′-3′ direction in an NTP-dependent manner 37 . Importantly, it has been reported that the SARS-Nsp13 sequence is conserved and indispensable, and is a necessary component for the replication of coronavirus. Therefore, it has been identified as a target for anti-viral drug discovery, but there are few reports about Nsp13 inhibitors 38, 39 .\",\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['95cc4248c19a3cc9a54ebcfa09fc7c80518dac5d',\n",
       "  'Journal Pre-proof Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods',\n",
       "  'Targets inhibiting virus structural proteins',\n",
       "  'Except for Spike protein, E protein (E-channel) possesses important biological functions for the structural integrity of coronavirus and host virulence. NRBD and CRBD of coronavirus N protein are needed for N proteins in host cells to bind with coronavirus RNA efficiently. Therefore, E protein or N protein (NRBD and CRBD domains) can be used as targets for the discovery of anti-viral drugs. Through virtual screening, many anti-bacterial, anti-viral, anti-tumor, anti-asthmatic, and anti-inflammatory drugs, etc. from ZINC database and our in-house natural products/derivatives database were found to display relatively good affinity to these targets. And the detailed results of virtual screening are given in Supplementary excel files.',\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['d3fb8500862db1ce9cc299443a6d31209fab5602',\n",
       "  'In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus',\n",
       "  'Part 1 Oral effectiveness/anti-2019-nCoV compound selection',\n",
       "  'Part 2 Traditional usage-compatible herbal selection qi-reinforcing drugs, antitussive antiasthmatics, pungent cool diaphoretics and phlegm-resolving medicines may all be used throughout the course of infection, whereas drugs belonging to the interior warming group may be best utilized in prevention.',\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['f726b9f9f1737e712581e2f613a68fed62a48eca',\n",
       "  'Journal Pre-proof Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods',\n",
       "  '3C-like main protease (3CLpro)',\n",
       "  \"It's worth mentioning, anti-asthmatic drug montelukast also showed low binding energy to 3CLpro. As shown in Fig. 5A , montelukast was well fitted into the active pocket of 3CLpro, in which lots of hydrophobic amino acids, just like Thr24, Leu27, His41, Phe140, Cys145, His163, Met165, Pro168 and His172 compose a relatively hydrophobic environment to contain the compound and stabilize its conformation. Hydrogen bonding was predicted between Asn142 and the carbonyl group of the compound (Fig. 5B ). DNA and RNA along the 5′-3′ direction in an NTP-dependent manner 37 . Importantly, it has been reported that the SARS-Nsp13 sequence is conserved and indispensable, and is a necessary component for the replication of coronavirus. Therefore, it has been identified as a target for anti-viral drug discovery, but there are few reports about Nsp13 inhibitors 38, 39 .\",\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['f726b9f9f1737e712581e2f613a68fed62a48eca',\n",
       "  'Journal Pre-proof Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods',\n",
       "  'Targets inhibiting virus structural proteins',\n",
       "  'Except for Spike protein, E protein (E-channel) possesses important biological functions for the structural integrity of coronavirus and host virulence. NRBD and CRBD of coronavirus N protein are needed for N proteins in host cells to bind with coronavirus RNA efficiently. Therefore, E protein or N protein (NRBD and CRBD domains) can be used as targets for the discovery of anti-viral drugs. Through virtual screening, many anti-bacterial, anti-viral, anti-tumor, anti-asthmatic, and anti-inflammatory drugs, etc. from ZINC database and our in-house natural products/derivatives database were found to display relatively good affinity to these targets. And the detailed results of virtual screening are given in Supplementary excel files.',\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['459c780b398aa89f292490a6b455845448b7d537',\n",
       "  'In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus',\n",
       "  'Part 1 Oral effectiveness/anti-2019-nCoV compound selection',\n",
       "  'Part 2 Traditional usage-compatible herbal selection qi-reinforcing drugs, antitussive antiasthmatics, pungent cool diaphoretics and phlegm-resolving medicines may all be used throughout the course of infection, whereas drugs belonging to the interior warming group may be best utilized in prevention.',\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['94e62a756a8f77d56f465194b69e260afad78eea',\n",
       "  'Potential Factors for Prediction of Disease Severity of COVID-19 Patients',\n",
       "  'Epidemiological and clinical characteristics of COVID-19 patients',\n",
       "  'The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org /10.1101 /10. /2020 occurrence of chest distress (p=0.046), anhelation (p=0.008) and asthma (p=0.002) ( Table 1) .',\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['94e62a756a8f77d56f465194b69e260afad78eea',\n",
       "  'Potential Factors for Prediction of Disease Severity of COVID-19 Patients',\n",
       "  'Discussion',\n",
       "  'The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org /10.1101 /10. /2020 effective indicators for disease progression, in order to provide appropriate treatment for severe patients early. Compared to mild patients, severe patients were older and had higher frequencies to be co-infected with bacteria, which is consistent with previous reports that critically ill patients were more likely to be older and had co-infection of bacteria [9] . Furthermore, severe patients were more likely to have chest distress and respiratory symptoms, such as anhelation and asthma. The clinical symptoms of COVID-19 patients are similar to those reported by other studies [6, 9, 10] . In terms of laboratory finding, IL6, IL10, ESR, CRP, APTT, D-D, ALB, AST, LDH and FIB were significantly higher in severe cases than mild cases, which indicate a degree of cardiac, live, coagulation function abnormality and infection, so more attention should be paid for these patients to avoid delayed treatment.',\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['72bec44d56da538afeabe871b4069ffe9b0906da',\n",
       "  'Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs',\n",
       "  'Results and Discussion',\n",
       "  'Among these 24 drugs, two FDA-approved drugs drew our attention. First, niclosamide, an antihelminthic drug, exhibited very potent antiviral activity against SARS-CoV-2 (IC 50 = 0.28 µM). Not surprisingly, its broad-spectrum antiviral effect has been well documented in the Second, ciclesonide is another interesting drug candidate for further development although its antiviral potency was much lower (IC 50 = 4.33 µM) than niclosamide. It is an inhaled corticosteroid used to treat asthma and allergic rhinitis 11 . A recent report by Matsuyama et al.',\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['6c7c93c25caa6d94c70c891e2446a4a12e729365',\n",
       "  'Title page Title: Acute myelitis after SARS-CoV-2 infection: a case report Acute myelitis after SARS-CoV-2 infection: a case report',\n",
       "  'Case introduction',\n",
       "  'A 66-year-old male was admitted to hospital for fever and fatigue of 2 days in Wuhan, China. He had no contact with patients with COVID-19. He developed fever without obvious cause on February 8, 2020, the highest body temperature was 39 ℃, with fatigue, without cough, asthma and dyspnea. He went to the outpatient clinic of Wuhan local hospital and was treated with oral moxifloxacin hydrochloride and oseltamivir for 5 days. On February 13, he performed a chest CT in the local lung hospital and found patchy changes in both lungs (Figure1.A&B). The test of novel coronavirus RNA nasopharyngeal swab was positive, then he was diagnosed with mild Covid-19. He was admitted to Wuhan Cabin Hospital and was treated in individual isolation. After a high fever (40 ℃ ) at night, he developed weakness of both lower limbs with urinary and bowel incontinence, culminating in flaccid lower extremity paralysis. His condition aggravated rapidly, and he was transferred to intensive care unit for critical care and treatment. Vital signs: Oxygen . CC-BY-NC 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.',\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['d070dc3ef2125fd891f3e023598831e23a145880',\n",
       "  'A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19',\n",
       "  'Discussion',\n",
       "  'In addition, the FDA-approved PARP1 inhibitor, olaparib, has been reported to protect against the LPS (Lipopolysaccharide)-induced acute lung and kidney injuries in a NF-κB-dependent manner in mice [49] . Numerous pre-clinical studies demonstrated that PARP1 inhibitors play an essential role in a range of inflammatory injuries and related diseases, especially the lung inflammatory disorders including ARDS (Acute Respiratory Distress Syndrome), COPD (Chronic Obstructive Pulmonary Disease) and asthma [40, 46, 50, 51] . All these studies suggest that PARP1 inhibitors are of high relevance to the treatment of the novel pneumonia caused by SARS-CoV-2 infection, possibly via their roles in modulating inflammatory response.',\n",
       "  array(['asthm'], dtype='<U5')],\n",
       " ['10e691d6bf9cfc219bb72a2761d37ae5f1677f77',\n",
       "  'Croup Is Associated with the Novel Coronavirus NL63',\n",
       "  'Discussion',\n",
       "  'Croup has been reported to occur mostly in boys, and it shows a peak occurrence in the second year of life and predominantly in the late fall or early winter season [12] . HCoV-NL63 infection seems to follow these trends: the ratio of boys infected to girls infected is 10:4, the median age in the outpatient group with HCoV-NL63 is 1.55 y, and this virus is circulating mainly in the winter months. Thus, it will be of interest to study the underlying biological reasons for the increased susceptibility of young boys to HCoV-NL63, as this may also explain the higher number of male patients with croup. A preferential occurrence in boys has been described for other respiratory diseases including asthma [13] , and human coronavirus infections have previously been associated with exacerbations of asthma [14] . It will therefore also be of interest to study this link for HCoV-NL63.',\n",
       "  array(['asthm', 'asthm'], dtype='<U5')]]"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "risk_design_outcome"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 581,
   "metadata": {},
   "outputs": [],
   "source": [
    "# data for smoke:\n",
    "\n",
    "smoke_pd = pd.DataFrame(smoke, columns = ['paper_id','title','section','text','risk1'\n",
    "                               , 'title_smoke', 'n_smoke', 'design', 'outcome', 'outcome_rank','design_rank'])\n",
    "# smoke_pd['rank_section'] = np.where(smoke_pd['section'] ==('discussion' or 'result'), 3, 0)\n",
    "smoke_pd['rank'] = smoke_pd['n_smoke'] + smoke_pd['outcome_rank']/10 + smoke_pd['design_rank']\n",
    "selected_smoke = smoke_pd.sort_values('rank', ascending = False).reset_index(drop = True)[0:10]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 559,
   "metadata": {},
   "outputs": [],
   "source": [
    "# data for diabete:\n",
    "\n",
    "diabete_pd = pd.DataFrame(diabete, columns = ['paper_id','title','section','text','risk1'\n",
    "                               , 'title_diabete', 'n_diabete', 'design', 'outcome', 'outcome_rank','design_rank'])\n",
    "\n",
    "diabete_pd['rank'] = diabete_pd['n_diabete'] + diabete_pd['outcome_rank']/10 + diabete_pd['design_rank']*2\n",
    "selected_diabete = diabete_pd.sort_values('rank', ascending = False).reset_index(drop = True)[0:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 690,
   "metadata": {},
   "outputs": [],
   "source": [
    "# data for pregnan:\n",
    "\n",
    "pregnan_pd = pd.DataFrame(pregnan, columns = ['paper_id','title','section','text','risk1'\n",
    "                               , 'title_pregnan', 'n_pregnan', 'design', 'outcome', 'outcome_rank','design_rank'])\n",
    "\n",
    "pregnan_pd['rank'] = pregnan_pd['n_pregnan'] + pregnan_pd['outcome_rank']/10 + pregnan_pd['design_rank']*2\n",
    "selected_pregnan = pregnan_pd.sort_values('rank', ascending = False).reset_index(drop = True)[0:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 645,
   "metadata": {},
   "outputs": [],
   "source": [
    "# data for ethnic:\n",
    "\n",
    "tubercul_pd = pd.DataFrame(race, columns = ['paper_id','title','section','text','risk1'\n",
    "                               , 'title_race', 'n_race', 'design', 'outcome', 'outcome_rank','design_rank'])\n",
    "\n",
    "tubercul_pd['rank'] = tubercul_pd['n_race']\n",
    "selected_tubercul = tubercul_pd.sort_values('rank', ascending = False).reset_index(drop = True)[0:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 662,
   "metadata": {},
   "outputs": [],
   "source": [
    "# meta = pd.read_csv('metadata.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 695,
   "metadata": {},
   "outputs": [],
   "source": [
    "# data_tuber = pd.merge(selected_tubercul, meta, how='left', left_on='paper_id', right_on='sha')\n",
    "# data_smoke = pd.merge(selected_smoke, meta, how='left', left_on='paper_id', right_on='sha')\n",
    "# data_diabete = pd.merge(selected_diabete, meta, how='left', left_on='paper_id', right_on='sha')\n",
    "data_pregnan = pd.merge(selected_pregnan, meta, how='left', left_on='paper_id', right_on='sha')\n",
    "\n",
    "pregnan = data_pregnan[['paper_id', 'title_x', 'text', 'risk1', \n",
    "        'design', 'rank',  'doi', \n",
    "        'abstract', 'publish_time', 'authors', 'journal',\n",
    "       'full_text_file']]\n",
    "pregnan.columns = ['doc_id', 'title', 'relevant_section', 'risk_factor', 'design', 'rank',  'doi', \n",
    "        'abstract', 'publish_time', 'authors', 'journal',\n",
    "       'text_body']\n",
    "pregnan.to_json('pregnan.json',orient = 'records')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 696,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[34mcorona_challenge\u001b[m\u001b[m/ \u001b[34mkaggle_annotated\u001b[m\u001b[m/ pregnan.json      tuberclosis.json\r\n",
      "diabete.json      metadata.csv      smoke.json\r\n"
     ]
    }
   ],
   "source": [
    "ls"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
